USFDA completes inspection of Jubilant Pharmova's API Manufacturing Facility at Nanjangud, India

Jubilant Pharmova Limited announced that the United States Food and Drug Administration (USFDA) has concluded inspection of the Active Pharmaceutical Ingredients (API) manufacturing facility at Nanjangud on December 13, 2022. The US FDA has issued eight observations pursuant to the completion of the inspection. The company will submit an action plan on the observations and will engage with US FDA for next steps.

Apollo Hospitals Enterprise raises Rs. 105 crores through NCDs

The Committee of Directors of Apollo Hospitals Enterprise Ltd, has today, i.e., December 14, 2022, approved the allotment of 1050 - Senior, Unsecured, Redeemable, Rated, Listed, Non-Convertible Debentures having face value Rs. 10,00,000/- each, for cash, aggregating to Rs. 105 crores, to ICICI Bank Ltd on private placement basis, on the terms and conditions as mentioned in the Placement Memorandum for the said Issue. The NCDs are proposed to be listed on the Wholesale Debt Market (WDM) Segment of NSE Limited.